Follow
← Back

Dicorate 250mg Tablet

Generic: Divalproex Sodium 250mg
Anti-epileptic drugTablet250mg22 brands · 6 makers in Nepal
Dicorate is Divalproex Sodium 250mg, an anti-epileptic drug made by Sun Pharmaceutical Industries Ltd. It is sold in Nepal in 1 and strip of 10 tablet er. Dicorate is one of 5 Dicorate products by Sun Pharmaceutical Industries Ltd. in the NepalDoc catalog.
BrandDicorate
Generic nameDivalproex Sodium
MakerSun Pharmaceutical Industries Ltd.
FormTablet
Strength250mg
Pack sizes1, strip of 10 tablet er, bottle of 100 ml Oral Solution
Source / स्रोतNepalDoc medicine catalog

The Dicorate family

Dicorate is a brand family of Sun Pharmaceutical Industries Ltd., sold in Nepal. The NepalDoc catalog lists 5 Dicorate products, all Divalproex Sodium.

Dicorate 250mg Tablet (this page)Divalproex Sodium · 250mg
Dicorate ER 500mg TabletDivalproex Sodium · 500mg
Dicorate ER 1gm TabletDivalproex Sodium · 1gm
Dicorate ER 250mg TabletDivalproex Sodium · 250mg
Dicorate 1000mg TabletDivalproex Sodium · 1000mg

What it's for

Divalproex sodium delayed-release tablets are an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures Prophylaxis of migraine headaches 1.1 Mania Divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder.

From the U.S. FDA-approved label for Divalproex Sodium. Full label: DailyMed.

Divalproex sodium delayed-release tablets are an anti-epileptic drug indicated for: Treatment of manic episodes associated with bipolar disorder Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures Prophylaxis of migraine headaches 1.1 Mania Divalproex sodium is a valproate and is indicated for the treatment of the manic episodes associated with bipolar disorder. A manic episode is a distinct period of abnormally and persistently elevated, expansive, or irritable mood. Typical symptoms of mania include pressure of speech, motor hyperactivity, reduced need for sleep, flight of ideas, grandiosity, poor judgment, aggressiveness, and possible hostility. The efficacy of divalproex sodium delayed-release tablets was established in 3-week trials with patients meeting DSM-III-R criteria for bipolar disorder who were hospitalized for acute mania. The safety and effectiveness of divalproex sodium delayed-release tablets for long-term use in mania, i.e., more than 3 weeks, has not been demonstrated in controlled clinical trials.

From the U.S. FDA-approved label for Divalproex Sodium. Full label: DailyMed.

Divalproex sodium delayed-release tablets are intended for oral administration. Patients should be informed to take divalproex sodium delayed-release tablets every day as prescribed. If a dose is missed it should be taken as soon as possible, unless it is almost time for the next dose.

Directions from the U.S. FDA-approved label for Divalproex Sodium — your doctor or pharmacist may advise differently.

Divalproex sodium delayed-release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction. Divalproex sodium delayed-release tablets are contraindicated in patients known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase γ (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder. Divalproex sodium delayed-release tablets are contraindicated in patients with known hypersensitivity to the drug.

Excerpt from the U.S. FDA-approved label for Divalproex Sodium. Talk to a pharmacist or doctor before use.

Hepatotoxicity; evaluate high risk populations and monitor serum liver tests Birth defects, decreased IQ, and neurodevelopmental disorders following in utero exposure; should not be used to treat women with epilepsy or bipolar disorder who are pregnant or who plan to become pregnant or to treat a woman of childbearing potential unless other medications have failed to provide adequate symptom control or are otherwise unacceptable Pancreatitis; divalproex sodium delayed-release tablets should ordinarily be discontinued Suicidal behavior or ideation; Antiepileptic drugs…

Warnings and precautions excerpt from the U.S. FDA-approved label for Divalproex Sodium — not a complete list. Talk to a pharmacist or doctor before use.

The following serious adverse reactions are described below and elsewhere in the labeling: Hepatic failure Birth defects Decreased IQ following in utero exposure Pancreatitis Hyperammonemic encephalopathy Suicidal behavior and ideation Bleeding and other hematopoietic disorders Hypothermia Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan hypersensitivity reactions Somnolence in the elderly Because…

Excerpt from the U.S. FDA-approved label for Divalproex Sodium — not a complete list. Talk to a pharmacist or doctor about side effects.

Desval 250mg TabletSun Pharmaceutical Industries Ltd.
Desval 500mg TabletSun Pharmaceutical Industries Ltd.
Desval ER 250mg TabletRanbaxy Laboratories Ltd.
Desval ER 500mg TabletRanbaxy Laboratories Ltd.
Dicorate 1000mg TabletSun Pharmaceutical Industries Ltd.
Dicorate ER 500mg TabletSun Pharmaceutical Industries Ltd.
Dicorate ER 1gm TabletSun Pharmaceutical Industries Ltd.
Dicorate ER 250mg TabletSun Pharmaceutical Industries Ltd.
Diva A 500mg CapsuleIntas Pharmaceuticals Ltd.
Diva A 250mg TabletIntas Pharmaceuticals Ltd.
Diva A 125mg TabletIntas Pharmaceuticals Ltd.
Diva A OD 1gm TabletIntas Pharmaceuticals Ltd.

22 brands · 6 makers in the NepalDoc catalog — see the full Divalproex Sodium guide →

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). Dispense in a tight, light-resistant container with a child-resistant closure.

Storage information from the U.S. FDA-approved label for Divalproex Sodium.

Questions & answers

What is Dicorate?

Dicorate 250mg Tablet is a Divalproex Sodium medicine made by Sun Pharmaceutical Industries Ltd. It comes as 250mg Tablet.

What is the generic name of Dicorate?

The generic name of Dicorate is Divalproex Sodium.

Which brands of Divalproex Sodium are available in Nepal?

22 brands of Divalproex Sodium are listed in the NepalDoc catalog, from 6 makers — including Desval 250mg Tablet, Desval 500mg Tablet, Desval ER 250mg Tablet, Desval ER 500mg Tablet, Dicorate 1000mg Tablet, Dicorate ER 500mg Tablet.

What are the side effects of Divalproex Sodium?

The following serious adverse reactions are described below and elsewhere in the labeling: Hepatic failure Birth defects Decreased IQ following in utero exposure Pancreatitis Hyperammonemic encephalopathy Suicidal behavior and ideation Bleeding and other hematopoietic disorders Hypothermia Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)/Multiorgan hypersensitivity reactions Somnolence in the elderly Because…

What is the price of Dicorate in Nepal?

NepalDoc does not list medicine prices. Prices are set by individual pharmacies in Nepal and change over time — this page confirms the brand sold in Nepal, its generic name, maker, strength and pack details so you can check the price at your pharmacy with confidence.

Full medicine guide Check on Medicine Board
+ Safety information

This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.

Share This
NepalDoc — Nepal's Healthcare Super-App (Beta) / नेपालको स्वास्थ्य सुपर-एप (बेटा).
Medicine information only — not medical advice. Confirm with a pharmacist or doctor.
No prices are shown — NepalDoc lists medicine information only.